Sökning: WFRF:(Jiang N)
> (2005-2009) >
Cyclooxygenase-2 in...
-
Barnes, N. L. P.
(författare)
Cyclooxygenase-2 inhibition : effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer
- Artikel/kapitelEngelska2007
Förlag, utgivningsår, omfång ...
-
2007-02-06
-
Springer Science and Business Media LLC,2007
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-113753
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-113753URI
-
https://doi.org/10.1038/sj.bjc.6603593DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Cyclooxygenase-2 (COX-2) is associated with poor-prognosis breast cancer. We used a nude mouse xenograft model to determine the effects of COX-2 inhibition in breast cancer. Oestrogen receptor (ER)-positive MCF7/HER2-18 and ER-negative MDAMB231 breast cancer cell lines were injected into nude mice and allowed to form tumours. Mice then received either chow containing Celecoxib (a COX-2 inhibitor) or control and tumour growth measured. Tumour proliferation, apoptosis, COX-2, lymphangiogenesis and angiogenesis were assessed by immunohistochemistry (IHC), Western blotting or Q-PCR. Celecoxib inhibited median tumour growth in MCF7/HER2-18 (58.7%, P=0.029) and MDAMB231 (46.3%, P=0.0002) cell lines compared to control. Cyclooxygenase-2 expression decreased following Celecoxib treatment (MCF7/HER2-18 median control 65.3% vs treated 22.5%, P=0.0001). Celecoxib increased apoptosis in MCF7/HER2-18 tumours (TUNEL 0.52% control vs 0.73% treated, P=0.0004) via inactivation of AKT (median pAKT(ser473) 57.3% control vs 35.5% treated, P=0.0001--confirmed at Western blotting). Q-PCR demonstrated decreased podoplanin RNA (lymphangiogenesis marker) in the MCF7/HER2-18 - median 2.9 copies treated vs 66.6 control (P=0.05) and MDAMB231-treated groups--median 160.7 copies vs 0.05 control copies (P=0.015), confirmed at IHC. Cyclooxygenase-2 is associated with high levels of activated AKT(ser473) and lymphangiogenesis in breast cancer. Cyclooxygenase-2 inhibition decreases tumour growth, and may potentially decrease recurrence, by inactivating AKT and decreasing lymphangiogenesis.
Ämnesord och genrebeteckningar
-
breast
-
cyclooxygenase-2
-
apoptosis
-
lymphangiogenesis
-
MEDICINE
-
MEDICIN
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Wärnberg, FredrikUppsala universitet,Endokrinkirurgi(Swepub:uu)fredwarn
(författare)
-
Farnie, G.
(författare)
-
White, D.
(författare)
-
Jiang, W
(författare)
-
Anderson, E.
(författare)
-
Bundred, N. J.
(författare)
-
Uppsala universitetEndokrinkirurgi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:British Journal of Cancer: Springer Science and Business Media LLC96:4, s. 575-5820007-09201532-1827
Internetlänk
Hitta via bibliotek
Till lärosätets databas